Arjan Rudolphus

1.9k total citations
32 papers, 1.4k citations indexed

About

Arjan Rudolphus is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Arjan Rudolphus has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 7 papers in Epidemiology. Recurrent topics in Arjan Rudolphus's work include Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Asthma and respiratory diseases (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Arjan Rudolphus is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Asthma and respiratory diseases (7 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). Arjan Rudolphus collaborates with scholars based in Netherlands, United Kingdom and United States. Arjan Rudolphus's co-authors include Joop H. Dijkman, Jan Stolk, Gert‐Jan Braunstahl, John Weinman, Margreet Scharloo, Jannie J. Abbink, Maarten J. Fischer, Pieter S. Hiemstra, Klaus F. Rabe and Dirk van Ranst and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Annals of the New York Academy of Sciences and CHEST Journal.

In The Last Decade

Arjan Rudolphus

32 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arjan Rudolphus Netherlands 19 863 384 220 188 113 32 1.4k
Jannie J. Abbink Netherlands 17 554 0.6× 142 0.4× 79 0.4× 80 0.4× 218 1.9× 23 1.2k
Raymond G. Hoffman United States 20 289 0.3× 236 0.6× 111 0.5× 531 2.8× 98 0.9× 35 1.9k
Lex Volovics Netherlands 11 815 0.9× 438 1.1× 170 0.8× 372 2.0× 84 0.7× 19 1.5k
Giuseppe Fiorentino Italy 19 362 0.4× 144 0.4× 79 0.4× 66 0.4× 64 0.6× 112 1.4k
Andrea Zanini Italy 20 1.1k 1.2× 785 2.0× 43 0.2× 101 0.5× 351 3.1× 38 1.8k
Naoko Sakamoto Japan 26 660 0.8× 101 0.3× 72 0.3× 405 2.2× 50 0.4× 90 2.0k
Douglas Case United States 21 199 0.2× 142 0.4× 95 0.4× 205 1.1× 49 0.4× 40 1.3k
August Zabernigg Austria 22 401 0.5× 131 0.3× 100 0.5× 684 3.6× 104 0.9× 57 1.6k
Michael A. LeNoir United States 20 401 0.5× 738 1.9× 41 0.2× 65 0.3× 179 1.6× 29 1.5k
Elroy D. Kursh United States 30 622 0.7× 92 0.2× 85 0.4× 195 1.0× 76 0.7× 76 2.2k

Countries citing papers authored by Arjan Rudolphus

Since Specialization
Citations

This map shows the geographic impact of Arjan Rudolphus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arjan Rudolphus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arjan Rudolphus more than expected).

Fields of papers citing papers by Arjan Rudolphus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arjan Rudolphus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arjan Rudolphus. The network helps show where Arjan Rudolphus may publish in the future.

Co-authorship network of co-authors of Arjan Rudolphus

This figure shows the co-authorship network connecting the top 25 collaborators of Arjan Rudolphus. A scholar is included among the top collaborators of Arjan Rudolphus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arjan Rudolphus. Arjan Rudolphus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Velzen, Patricia van, Gerben ter Riet, Paul Bresser, et al.. (2017). Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial. The Lancet Respiratory Medicine. 5(6). 492–499. 32 indexed citations
2.
Kappen, Jasper H., et al.. (2017). Lymphomatoid granulomatosis with pulmonary and gastrointestinal involvement. BMJ Case Reports. 2017. bcr2016218369–bcr2016218369. 5 indexed citations
3.
Huisstede, Astrid van, et al.. (2017). Effect of an Outpatient Pulmonary Rehabilitation Program on Exercise Tolerance and Asthma Control in Obese Asthma Patients. Journal of Cardiopulmonary Rehabilitation and Prevention. 37(3). 214–222. 15 indexed citations
4.
Rudolphus, Arjan, et al.. (2014). COPD: Pulmonary damage beyond FEV1. 44. 800. 1 indexed citations
5.
Fischer, Maarten J., Margreet Scharloo, Jannie J. Abbink, et al.. (2010). The dynamics of illness perceptions: Testing assumptions of Leventhal's common‐sense model in a pulmonary rehabilitation setting. British Journal of Health Psychology. 15(4). 887–903. 49 indexed citations
6.
Fischer, Maarten J., Margreet Scharloo, Jannie J. Abbink, et al.. (2010). Concerns About Exercise Are Related to Walk Test Results in Pulmonary Rehabilitation for Patients with COPD. International Journal of Behavioral Medicine. 19(1). 39–47. 26 indexed citations
7.
Fischer, Maarten J., Margreet Scharloo, Jannie J. Abbink, et al.. (2009). Drop-out and attendance in pulmonary rehabilitation: The role of clinical and psychosocial variables. Respiratory Medicine. 103(10). 1564–1571. 158 indexed citations
8.
Vliet, Evelyn P.M. van, Ewout W. Steyerberg, Arjan Rudolphus, et al.. (2008). The effects of guideline implementation for proton pump inhibitor prescription on two pulmonary medicine wards. Alimentary Pharmacology & Therapeutics. 29(2). 213–221. 14 indexed citations
9.
Vliet, Evelyn P.M. van, et al.. (2008). Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards. European Journal of Gastroenterology & Hepatology. 20(7). 608–612. 40 indexed citations
10.
Bogaard, J. M., et al.. (2007). Paraesophageal Hiatal Hernia-Induced Dyspnea. Respiration. 78(1). 105–105. 1 indexed citations
11.
Fischer, Maarten J., Margreet Scharloo, Jannie J. Abbink, et al.. (2007). Participation and drop-out in pulmonary rehabilitation: a qualitative analysis of the patient's perspective. Clinical Rehabilitation. 21(3). 212–221. 89 indexed citations
12.
Cornelissen, Robin, et al.. (2007). Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma. Radiation Oncology. 2(1). 2–2. 27 indexed citations
13.
Rudolphus, Arjan, et al.. (2003). [Severe respiratory symptoms following the use of waterproofing sprays].. PubMed. 147(24). 1185–8. 14 indexed citations
14.
Dirksen, Asger, Joop H. Dijkman, Flemming Madsen, et al.. (1999). A Randomized Clinical Trial of α1-Antitrypsin Augmentation Therapy. American Journal of Respiratory and Critical Care Medicine. 160(5). 1468–1472. 347 indexed citations
15.
Steffens, Gerd, Regina Heinzel‐Wieland, D. Saunders, et al.. (1993). Oxidation Resistant Muteins of Antileukoproteinase as Potential Therapeutic Agents. Birkhäuser Basel eBooks. 42. 111–121. 2 indexed citations
16.
Kramps, Johannes A., et al.. (1992). Proteinase/Proteinase Inhibitor Imbalance in Sputum Sol Phases from Patients with Chronic Obstructive Pulmonary Disease. CHEST Journal. 102(5). 1470–1476. 31 indexed citations
17.
Stolk, Jan, Arjan Rudolphus, Philip R. Davies, et al.. (1992). Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. The Journal of Pathology. 167(3). 349–356. 60 indexed citations
18.
Kramps, J. A., Arjan Rudolphus, Jan Stolk, Luc Willems, & Joop H. Dijkman. (1991). Role of Antileukoprotease in the Human Lung. Annals of the New York Academy of Sciences. 624(1). 97–108. 28 indexed citations
19.
Rudolphus, Arjan, Regina Heinzel‐Wieland, D. Saunders, et al.. (1991). Oxidation-resistant variants of recombinant anti-leucoprotease are better inhibitors of human-neutrophil-elastase-induced emphysema in hamsters than natural recombinant antileucoprotease. Clinical Science. 81(6). 777–784. 14 indexed citations
20.
Stolk, Jan, Arjan Rudolphus, & J. A. Kramps. (1991). Lipopolysaccharide‐Induced Alveolar Wall Destruction in the Hamster Is Inhibited by Intratracheal Treatment with r‐Secretory Leukocyte Protease Inhibitor. Annals of the New York Academy of Sciences. 624(1). 350–352. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jannie J. Abbink Breakdown of academic impact, for papers by Raymond G. Hoffman Breakdown of academic impact, for papers by Lex Volovics Breakdown of academic impact, for papers by Giuseppe Fiorentino Breakdown of academic impact, for papers by Andrea Zanini Breakdown of academic impact, for papers by Naoko Sakamoto Breakdown of academic impact, for papers by Douglas Case Breakdown of academic impact, for papers by August Zabernigg Breakdown of academic impact, for papers by Michael A. LeNoir Breakdown of academic impact, for papers by Elroy D. Kursh
Rankless by CCL
2026